The quarter materially exceeded the standing estimate. Published expectations called for roughly a $0.06 loss per share and about $98.7 million of revenue; Smith & Wesson instead delivered $0.06 of diluted EPS and $112.6 million of sales, making this a clear earnings and revenue beat. The revenue result was also a sharp year-over-year rebound: “Net sales were $112.6million, an increase of $27.5million, or 32.3%, from the comparable quarter last year.”
| Metric | Q1 FY27 | Q1 FY26 / expectation | Read |
|---|---|---|---|
| Net sales | $112.6M (Financial Highlights) | $85.1M prior year; ~$98.7M consensus | Beat |
| Gross margin | 28.7% (Financial Highlights) | 25.9% prior year | Up, but inflated by refund |
| GAAP diluted EPS | $0.06 (Financial Highlights) | $(0.08) prior year; roughly $(0.06) consensus | Beat |
| Adjusted EBITDAS | $13.8M / 12.2% margin (Adjusted EBITDAS reconciliation) | $7.4M / 8.7% prior year | Improved |
| Operating cash flow | $(8.8)M (Cash Flow statement) | $(8.1)M prior year | Worse |
| Free cash flow | $(20.8)M (Free Cash Flow reconciliation) | $(12.4)M prior year | Worse |
| Inventory | $180.7M (Balance Sheet) | $156.3M at April 30, 2026 | Higher |
The profit beat is real, but margin quality is weaker than the headline suggests. Gross margin rose to 28.7% from 25.9%, but the company received $2.9 million of tariff refunds that added roughly 260 basis points and will not recur. “These refunds favorably impacted gross margin by approximately 260 basis points and represented a non-recurring benefit.” 〔0〕 Excluding that benefit, the underlying margin improvement was only about 20 basis points year over year, so the earnings upside appears driven more by volume and operating leverage than by a durable cost improvement.
The balance-sheet rebound is consuming cash. Inventory increased by about $24.4 million from April 30, while capital spending nearly tripled year over year to $11.9 million; free cash flow consequently deteriorated to negative $20.8 million from negative $12.4 million. Cash fell to $18.7 million from $28.2 million even as notes and loans payable rose to $39.2 million from $19.1 million (Balance Sheet; Cash Flow statement). That does not negate the earnings beat, but it makes the recovery more dependent on inventory converting into sales and on the relocation and capacity investments paying off.
Management largely reaffirmed the path already expected. The company maintained its fiscal 2027 revenue-growth outlook of approximately 5%–7% and expects second-quarter sales roughly 10% above last year, so the forward message is confirmation rather than a fresh upward reset. The new information is that demand is arriving well ahead of the market’s near-term estimate, while the filing provides no stronger full-year revenue target or profitability upgrade.
Net read: a clear beat with meaningful execution upside, tempered by one-time tariff help and weaker cash conversion. Against expectations, the revenue and EPS surprise is decisively favorable; the main question shifts from whether demand is recovering to whether Smith & Wesson can sustain margins and turn the higher inventory and capital spending into cash.
Read the original 8-K on SEC EDGAR ↗